OrbiMed’s Synthorx, Inc. Common Stock THOR Stock Holding History

OrbiMed’s Portfolio THOR Stock Details THOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,316,355	Closed	-$372M	–	170
2019 Q4	$372M	Hold	5,316,355	–	–	5.3%	2
2019 Q3	$86.5M	Hold	5,316,355	–	–	1.64%	19
2019 Q2	$71.8M	Hold	5,316,355	–	–	1.11%	29
2019 Q1	$108M	Hold	5,316,355	–	–	1.68%	16
2018 Q4	$92.4M	Buy	+5,316,355	New	+$77.1M	1.71%	14

OrbiMed's THOR Position: Q1 2020 in Review

OrbiMed sold out of Synthorx, Inc. Common Stock (THOR) in Q1 2020, closing a stake of 5,316,355 shares — an estimated $372M sold.

OrbiMed first reported a position in THOR in Q4 2018 and held it in 5 quarters. The position peaked at $372M in Q4 2019. 0 funds tracked by Wall St. Rank hold THOR as of Q1 2020.

OrbiMed reported no remaining Synthorx, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
OrbiMed sold 5,316,355 Synthorx, Inc. Common Stock shares in Q1 2020, an estimated $372M.
OrbiMed first reported a position in Synthorx, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
OrbiMed's Synthorx, Inc. Common Stock position peaked at $372M in Q4 2019.
0 funds tracked by Wall St. Rank held Synthorx, Inc. Common Stock as of Q1 2020.

Based on OrbiMed's 13F filing for Q1 2020, filed 15 May 2020.